Intersect ENT, Inc. / Fundamentals

    Income statement

    Net revenue
    €89.75M
    Cost of goods sold
    €25.24M
    Gross profit
    €64.51M
    SG&A expenses
    €105.31M
    R&D expenses
    €26.73M
    EBITDA
    -€136.83M
    D&A
    €3.46M
    EBIT
    -€128.89M
    Interest expenses
    €6.14M
    EBT
    -€146.44M
    Tax expenses
    €678.35K
    Net income
    -€147.11M

    Cash flow statement

    Net deferred tax
    -€1.09M
    Non-cash items
    €77.11M
    Changes in working capital
    -€7.52M
    Operating cash flow
    -€60.03M
    Capex
    €1.48M
    Other investing cash flow
    €0.00
    Net investing cash flow
    €24.90M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €6.03M
    Debt repayment
    €0.00
    Other financing cash flow
    €44.26M
    Net financing cash flow
    €44.26M
    Foreign exchange effects
    -€238.20K
    Net change in cash
    €8.44M
    Cash at end of period
    €36.75M
    Free cash flow
    -€58.55M

    Balance sheet

    Cash and cash equivalents
    €22.08M
    Cash and short-term investments
    €43.70M
    Total receivables
    €11.42M
    Inventory
    €15.31M
    Other current assets
    €5.07M
    Total current assets
    €75.50M
    Property, plant & equipment
    €17.54M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €16.91M
    Total non-current assets
    €34.45M
    Total assets
    €109.94M
    Accounts payable
    €7.92M
    Short-term debt
    €0.00
    Other current liabilities
    €32.13M
    Total current liabilities
    €40.06M
    Long-term debt
    €135.99M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €15.05M
    Total non-current liabilities
    €151.04M
    Total liabilities
    €191.10M
    Common stock
    €29.34K
    Retained earnings
    -€424.19M
    Other equity
    -€45.74K
    Total equity
    -€81.15M
    Total liabilities and shareholders' equity
    €109.94M

    Company information

    Market capitalization
    €0.00
    Employees
    433
    Enterprise Value
    €103.66M

    Company ratios

    Gross margin
    71.9% Much better than peer group: -169.2%
    EBITDA margin
    -152.5% Much better than peer group: -8,489.0%
    EBIT margin
    -143.6% Much better than peer group: -10,287.9%
    EBT margin
    -163.2% Much better than peer group: -6,682.8%
    Net margin
    -163.9% Much better than peer group: -10,205.6%
    ROE
    181.3% Much better than peer group: -22.5%
    ROA
    -133.8% Much better than peer group: -4,430.6%
    Asset turnover
    81.6% Much worse than peer group: 360.2%
    FCF margin
    -68.5% Much better than peer group: -4,303.8%
    FCF yield
    0.0%
    Efficiency ratio
    252.5%
    Net sales per employee
    €207.28K
    Net income per employee
    -€339.76K

    Notifications